Literature DB >> 1825014

Tay-Sachs disease in Moroccan Jews: deletion of a phenylalanine in the alpha-subunit of beta-hexosaminidase.

R Navon1, R L Proia.   

Abstract

Tay-Sachs disease is an inherited lysosomal storage disorder caused by defects in the beta-hexosaminidase alpha-subunit gene. The carrier frequency for Tay-Sachs disease is significantly elevated in both the Ashkenazi Jewish and Moroccan Jewish populations but not in other Jewish groups. We have found that the mutations underlying Tay-Sachs disease in Ashkenazi and Moroccan Jews are different. Analysis of a Moroccan Jewish Tay-Sachs patient had revealed an in-frame deletion (delta F) of one of the two adjacent phenylalanine codons that are present at positions 304 and 305 in the alpha-subunit sequence. The mutation impairs the subunit assembly of beta-hexosaminidase A, resulting in an absence of enzyme activity. The Moroccan patient was found also to carry, in the other alpha-subunit allele, a different, and as yet unidentified, mutation which causes a deficit of mRNA. Analysis of obligate carriers from six unrelated Moroccan Jewish families showed that three harbor the delta F mutation, raising the possibility that this defect may be a prevalent mutation in this ethnic group.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825014      PMCID: PMC1683003     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  28 in total

1.  A deletion involving Alu sequences in the beta-hexosaminidase alpha-chain gene of French Canadians with Tay-Sachs disease.

Authors:  R Myerowitz; N D Hogikyan
Journal:  J Biol Chem       Date:  1987-11-15       Impact factor: 5.157

2.  Gene encoding the human beta-hexosaminidase beta chain: extensive homology of intron placement in the alpha- and beta-chain genes.

Authors:  R L Proia
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

3.  Frequency of three Hex A mutant alleles among Jewish and non-Jewish carriers identified in a Tay-Sachs screening program.

Authors:  B H Paw; P T Tieu; M M Kaback; J Lim; E F Neufeld
Journal:  Am J Hum Genet       Date:  1990-10       Impact factor: 11.025

4.  Population dynamics of Tay-Sachs disease. I. Reproductive fitness and selection.

Authors:  N C Myrianthopoulos; S M Aronson
Journal:  Am J Hum Genet       Date:  1966-07       Impact factor: 11.025

5.  Isolation of cDNA clones coding for the alpha-subunit of human beta-hexosaminidase. Extensive homology between the alpha- and beta-subunits and studies on Tay-Sachs disease.

Authors:  R G Korneluk; D J Mahuran; K Neote; M H Klavins; B F O'Dowd; M Tropak; H F Willard; M J Anderson; J A Lowden; R A Gravel
Journal:  J Biol Chem       Date:  1986-06-25       Impact factor: 5.157

6.  The major defect in Ashkenazi Jews with Tay-Sachs disease is an insertion in the gene for the alpha-chain of beta-hexosaminidase.

Authors:  R Myerowitz; F C Costigan
Journal:  J Biol Chem       Date:  1988-12-15       Impact factor: 5.157

7.  Human beta-hexosaminidase alpha chain: coding sequence and homology with the beta chain.

Authors:  R Myerowitz; R Piekarz; E F Neufeld; T B Shows; K Suzuki
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

8.  A splicing defect due to an exon-intron junctional mutation results in abnormal beta-hexosaminidase alpha chain mRNAs in Ashkenazi Jewish patients with Tay-Sachs disease.

Authors:  K Ohno; K Suzuki
Journal:  Biochem Biophys Res Commun       Date:  1988-05-31       Impact factor: 3.575

9.  Cloning and sequence analysis of a cDNA encoding the beta-subunit of mouse beta-hexosaminidase.

Authors:  B Bapat; M Ethier; K Neote; D Mahuran; R A Gravel
Journal:  FEBS Lett       Date:  1988-09-12       Impact factor: 4.124

10.  Molecular cloning of the cDNA which encodes beta-N-acetylhexosaminidase A from Dictyostelium discoideum. Complete amino acid sequence and homology with the human enzyme.

Authors:  T R Graham; H P Zassenhaus; A Kaplan
Journal:  J Biol Chem       Date:  1988-11-15       Impact factor: 5.157

View more
  7 in total

1.  Cloning and sequence analysis of a cDNA encoding the alpha-subunit of mouse beta-N-acetylhexosaminidase and comparison with the human enzyme.

Authors:  T Beccari; J Hoade; A Orlacchio; J L Stirling
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

2.  Linkage disequilibrium mapping places the gene causing familial Mediterranean fever close to D16S246.

Authors:  E N Levy; Y Shen; A Kupelian; L Kruglyak; I Aksentijevich; E Pras; J E Balow; B Linzer; X Chen; D A Shelton; D Gumucio; M Pras; M Shohat; J I Rotter; N Fischel-Ghodsian; R I Richards; D L Kastner
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

3.  Familial Mediterranean fever (FMF) in Moroccan Jews: demonstration of a founder effect by extended haplotype analysis.

Authors:  I Aksentijevich; E Pras; L Gruberg; Y Shen; K Holman; S Helling; L Prosen; G R Sutherland; R I Richards; M Dean
Journal:  Am J Hum Genet       Date:  1993-09       Impact factor: 11.025

4.  Beta-hexosaminidase splice site mutation has a high frequency among non-Jewish Tay-Sachs disease carriers from the British Isles.

Authors:  E C Landels; P M Green; I H Ellis; A H Fensom; M Bobrow
Journal:  J Med Genet       Date:  1992-08       Impact factor: 6.318

5.  The molecular basis of HEXA mRNA deficiency caused by the most common Tay-Sachs disease mutation.

Authors:  D J Boles; R L Proia
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

6.  Alternative splicing of RNA triplets is often regulated and accelerates proteome evolution.

Authors:  Robert K Bradley; Jason Merkin; Nicole J Lambert; Christopher B Burge
Journal:  PLoS Biol       Date:  2012-01-03       Impact factor: 8.029

7.  A mutation in a mild form of galactosialidosis impairs dimerization of the protective protein and renders it unstable.

Authors:  X Y Zhou; N J Galjart; R Willemsen; N Gillemans; H Galjaard; A d'Azzo
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.